JIANGSU, Cina, HEIDELBERG, Germania e CAMBRIDGE, Mass.–(BUSINESS WIRE)–Jiangsu Hengrui Pharmaceuticals Co., Ltd. (“Hengrui Pharma”), azienda farmaceutica globale incentrata sull’innovazione scientifica e tecnologica, e Novaliq GmbH (“Novaliq”), un’az…
Category: Business
Resumen: Gran avance en oftalmología: Heng Qin® de Hengrui (colirio de perfluorohexiloctano) aprobado como primer tratamiento para la sequedad ocular asociada a la Disfunción de las glándulas de Meibomio
JIANGSU, China y HEIDELBERG, Alemania y CAMBRIDGE, Massachusetts–(BUSINESS WIRE)–Jiangsu Hengrui Pharmaceuticals Co. Ltd. («Hengrui Pharma»), una compañía farmacéutica internacional centrada en la innovación científica y tecnológica, y Novaliq GmbH (…
Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)
GENEVA–(BUSINESS WIRE)–Alcon to Acquire LumiThera and its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)
Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the C…
Despite Majority of Americans Struggling with the Impact of Poor Eyesight and Eye Health on Daily Life, More than Half Are Delaying or Avoiding Eye Care
NEW YORK–(BUSINESS WIRE)– #EyeCare–New Versant Health study finds 86% of Americans would seek eye exams if linked to overall health. Education, access and tech drive vision benefit use.
Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter financial results on Wednesday, July 30, 2025. The…
Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to live better, today announced that its subsidiaries, Bausch+L…
GenSight Biologics Announces Significant Milestone in New Manufacturing Partnership with Catalent
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
GenSight Biologics annonce une avancée majeure dans son nouveau partenariat de fabrication avec Catalent
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible au PEA-PME), société biopharmaceutique spécialisée dans le développement et la commercialisation de thérapies géniques innovantes pour les mala…
Qlaris Bio to Present New Clinical and Preclinical Data on QLS-111 at 2025 World Glaucoma Congress
DEDHAM, Mass.–(BUSINESS WIRE)–Qlaris Bio, Inc., a clinical‐stage biotechnology company dedicated to developing first‐in‐class therapies for glaucoma, today announced that new data from studies of its lead investigational compound QLS-111 will be pres…
OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious neu…
Alcon Introduces Clareon PanOptix Pro in Canada, Delivering the Lowest Light Scatter of any Trifocal IOL
TORONTO–(BUSINESS WIRE)– #AlconCanada–Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOptix® Pro intraocular lens (IOL) for cataract patients in Canada. Pa…
Alcon annonce l’arrivée de Clareon PanOptix Pro au Canada, une lentille intraoculaire réduisant la dispersion de la lumière comme aucune autre LIO trifocale
TORONTO–(BUSINESS WIRE)–Alcon (SIX/NYSE : ALC), le chef de file mondial en matière de soins oculaires dédié à aider les gens à voir avec clarté, a annoncé aujourd’hui l’approbation de la lentille intraoculaire (LIO) ClareonMD PanOptix MD Pro pour les…
Sling Therapeutics Appoints Ken Lock as Chief Commercial Officer
ANN ARBOR, Mich.–(BUSINESS WIRE)–Sling Therapeutics Appoints Ken Lock as Chief Commercial Officer
Sightview Names Tycene Fritcher as CEO
DURHAM, N.C.–(BUSINESS WIRE)– #EHR–Sightview, the only electronic health record and practice management partner focused solely on eyecare, has named Tycene Fritcher as CEO.
HOYA Vision Care Unveils Updates from the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting
SALT LAKE CITY–(BUSINESS WIRE)–HOYA Vision Care (https://www.hoyavision.com/) today announced new clinical evidence from three key clinical studies highlighting the impact of Defocus Incorporated Multiple Segments (D.I.M.S.) Technology. The results w…
As mais recentes tecnologias cirúrgicas inovadoras da Alcon, o UNITY® VCS e o UNITY® CS, são aprovadas no Brasil
SÃO PAULO–(BUSINESS WIRE)– #Alcon–A Alcon, líder global em cuidados com a visão dedicada a ajudar as pessoas a verem de forma brilhante, anuncia que o equipamento para cirurgias de retina e vítreo e de catarata (VCS/CS) UNITY®, bem como o equipament…
20/20 Onsite Expands Mobile Vision Fleet, Strengthening Nationwide Reach and Clinical Trial Support Capacity
BOSTON–(BUSINESS WIRE)–20/20 Onsite, the leading provider of point-of-need ophthalmic services for clinical trials, announces the deployment of its latest mobile vision clinic, bringing its fleet to 16 units, including a mix of mobile clinics, pods, …
Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals
NASHVILLE, Tenn. & TAIPEI, Taiwan–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, and Taiwan-based Formosa Pharmaceuticals (“Formosa”, 6838.TW), today announced a licensing agreement, whereby …
Virginia G. Piper Charitable Trust Names Laura Smith as Director of Eyes On Learning
PHOENIX–(BUSINESS WIRE)– #Arizona–Virginia G. Piper Charitable Trust has appointed Laura Smith as the new director of Eyes On Learning, a coalition of state, local, and national organizations dedicated to improving the vision health of Arizona’s chi…